Overview This page contains the latest trade data of Penicillins and streptomycins, derivs, in dosage. In 2022, Penicillins and streptomycins, derivs, in dosage were the world's 996th most traded product, with a total trade of $3.66B. Between 2021 and 2022 the exports of Penicillins and streptomycins, derivs, in dosage grew by 5.08%, from $3.49B to $3.66B. Trade in Penicillins and streptomycins, derivs, in dosage represent 0.015% of total world trade.
Penicillins and streptomycins, derivs, in dosage are a part of Packaged Medicaments.
Exports In 2022 the top exporters of Penicillins and streptomycins, derivs, in dosage were India ($543M), Austria ($374M), Italy ($312M), United Kingdom ($264M), and China ($252M).
Imports In 2022 the top importers of Penicillins and streptomycins, derivs, in dosage were United States ($411M), Germany ($218M), France ($195M), Egypt ($189M), and Japan ($104M).
Ranking Penicillins and streptomycins, derivs, in dosage ranks 2760th in the Product Complexity Index (PCI).
Description Penicillin and streptomycin are used to treat bacterial infections. Penicillin is currently the drug of choice for bacterial pneumonia, strep throat, and syphilis, as well as to prevent and treat rheumatic fever. Streptomycin is the drug of choice for tuberculosis.